MedTrace Logo

Vitamin C Supplementation as a Preventive Treatment of Diabetic Peripheral Neuropathy

NCT00634998 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 10

Last updated 2023-04-27

No results posted yet for this study

Summary

The purpose of this pilot study is to determine whether vitamin C supplementation is beneficial in treating and/or preventing diabetic peripheral neuropathy in people with type 2 diabetes.

Conditions

  • Diabetic Neuropathies

Interventions

DIETARY_SUPPLEMENT

Vitamin C

1000mg Vitamin C capsules orally twice daily

DIETARY_SUPPLEMENT

Placebo

1000mg Placebo capsules orally twice daily for 90 days

Sponsors & Collaborators

  • Washington State University

    lead OTHER

Principal Investigators

  • Joshua J Neumiller, PharmD · Washington State University

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
50 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-11-30
Primary Completion
2008-08-31
Completion
2008-08-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00634998 on ClinicalTrials.gov